PLEKHH3

gene
On this page

Also known as FLJ21019

Summary

PLEKHH3 (pleckstrin homology, MyTH4 and FERM domain containing H3, HGNC:26105) is a protein-coding gene on chromosome 17q21.2, encoding Pleckstrin homology domain-containing family H member 3 (Q7Z736).

Located in extracellular space.

Source: NCBI Gene 79990 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 155 total
  • MANE Select transcript: NM_024927

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26105
Approved symbolPLEKHH3
Namepleckstrin homology, MyTH4 and FERM domain containing H3
Location17q21.2
Locus typegene with protein product
StatusApproved
AliasesFLJ21019
Ensembl geneENSG00000068137
Ensembl biotypeprotein_coding
Entrez79990

Gene structure

Transcript identifiers

Ensembl transcripts: 17 — 11 protein_coding, 3 protein_coding_CDS_not_defined, 2 retained_intron, 1 nonsense_mediated_decay

ENST00000293349, ENST00000456950, ENST00000587627, ENST00000591022, ENST00000591196, ENST00000591476, ENST00000591490, ENST00000591544, ENST00000592974, ENST00000895611, ENST00000895612, ENST00000917129, ENST00000949018, ENST00000949019, ENST00000949020, ENST00000949021, ENST00000949022

RefSeq mRNA: 2 — MANE Select: NM_024927 NM_001411112, NM_024927

CCDS: CCDS11434, CCDS92327

Canonical transcript exons

ENST00000591022 — 13 exons

ExonStartEnd
ENSE000010591854267099442671130
ENSE000012199204266991842670376
ENSE000029116354267640242676994
ENSE000034594454267339942673556
ENSE000034603404267135142671558
ENSE000034947154267393442674013
ENSE000035152044267057342670705
ENSE000035594064266943042669621
ENSE000035698504267364342673834
ENSE000035718024267208642672392
ENSE000036214934267317642673296
ENSE000036257674266791442668303
ENSE000036411614267435442674409

Expression profiles

Bgee: expression breadth ubiquitous, 202 present calls, max score 97.28.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.5444 / max 111.1305, expressed in 1564 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1661767.15511499
1661771.81681115
1661740.3062137
1661750.2663119

Top tissues by expression

247 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lower esophagus mucosaUBERON:003583497.28gold quality
body of pancreasUBERON:000115096.64gold quality
right coronary arteryUBERON:000162593.59gold quality
esophagus mucosaUBERON:000246993.30gold quality
ectocervixUBERON:001224993.23gold quality
body of stomachUBERON:000116192.87gold quality
apex of heartUBERON:000209892.30gold quality
endocervixUBERON:000045892.14gold quality
left uterine tubeUBERON:000130391.74gold quality
tibial arteryUBERON:000761091.46gold quality
popliteal arteryUBERON:000225091.45gold quality
descending thoracic aortaUBERON:000234591.29gold quality
ascending aortaUBERON:000149691.19gold quality
right ovaryUBERON:000211891.15gold quality
aortaUBERON:000094791.12gold quality
thoracic aortaUBERON:000151591.08gold quality
adenohypophysisUBERON:000219690.76gold quality
mucosa of stomachUBERON:000119990.72gold quality
left coronary arteryUBERON:000162690.43gold quality
esophagusUBERON:000104390.40gold quality
body of uterusUBERON:000985390.23gold quality
hindlimb stylopod muscleUBERON:000425290.08gold quality
left ovaryUBERON:000211989.92gold quality
right adrenal glandUBERON:000123389.88gold quality
skin of abdomenUBERON:000141689.65gold quality
right adrenal gland cortexUBERON:003582789.65gold quality
left adrenal gland cortexUBERON:003582589.44gold quality
skin of legUBERON:000151189.37gold quality
esophagogastric junction muscularis propriaUBERON:003584189.31gold quality
gastrocnemiusUBERON:000138889.16gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.87

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

32 targeting PLEKHH3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4455100.0065.481587
HSA-MIR-10401-5P99.9965.79948
HSA-MIR-451499.9967.101870
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-365899.9673.874379
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-6772-5P99.9467.01577
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-129-5P99.8870.263273
HSA-MIR-806799.8669.592260
HSA-MIR-60999.8264.26505
HSA-MIR-6885-3P99.7570.363187
HSA-MIR-128399.6972.423009
HSA-MIR-10394-5P99.6566.831852
HSA-MIR-120599.6566.761826
HSA-MIR-1249-5P99.6166.552049
HSA-MIR-6797-5P99.6166.552084
HSA-MIR-613299.6065.831554
HSA-MIR-6836-5P99.6065.621538
HSA-MIR-4762-5P99.5768.541424
HSA-MIR-7844-5P99.5568.561428
HSA-MIR-6722-3P99.4567.621919
HSA-MIR-1909-3P99.0366.561662
HSA-MIR-392698.9569.261438
HSA-MIR-6501-3P98.7167.451480
HSA-MIR-708-3P97.5068.671082
HSA-MIR-6748-3P97.2065.66836
HSA-MIR-6895-5P97.0564.96522
HSA-MIR-339-5P96.7366.01820

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioPLEKHH3ENSDARG00000070174
mus_musculusPlekhh3ENSMUSG00000035172
rattus_norvegicusPlekhh3ENSRNOG00000020238

Protein

Protein identifiers

Pleckstrin homology domain-containing family H member 3Q7Z736 (reviewed: Q7Z736)

All UniProt accessions (3): Q7Z736, K7EK04, X6R3U4

UniProt curated annotations — full annotation on UniProt →

Isoforms (4)

UniProt IDNamesCanonical?
Q7Z736-11yes
Q7Z736-22
Q7Z736-33
Q7Z736-44

RefSeq proteins (2): NP_001398041, NP_079203* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000299FERM_domainDomain
IPR000857MyTH4_domDomain
IPR001849PH_domainDomain
IPR011993PH-like_dom_sfHomologous_superfamily
IPR014352FERM/acyl-CoA-bd_prot_sfHomologous_superfamily
IPR019748FERM_centralDomain
IPR019749Band_41_domainDomain
IPR035963FERM_2Homologous_superfamily
IPR038185MyTH4_dom_sfHomologous_superfamily
IPR051724Actin_motor_MyosinFamily

Pfam: PF00373, PF00784, PF21989

UniProt features (26 total): splice variant 7, compositionally biased region 4, region of interest 4, modified residue 3, domain 3, sequence conflict 2, signal peptide 1, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7Z736-F174.530.43

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3): 30, 638, 642

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 100 (showing top): GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, AP1_01, PAX4_01, GCANCTGNY_MYOD_Q6, TTTGTAG_MIR520D, AREB6_03, LINDGREN_BLADDER_CANCER_CLUSTER_3_DN, CREBP1_Q2, AP1_Q4_01, TGCTGAY_UNKNOWN, OCT1_03, BACH2_01, ARGGGTTAA_UNKNOWN, TGANTCA_AP1_C, NRF2_Q4

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (2): obsolete extracellular space (GO:0005615), cytoskeleton (GO:0005856)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membraneless organelle1

Protein interactions and networks

STRING

728 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PLEKHH3WDR49Q8IV35577
PLEKHH3GRIFINA4D1Z8483
PLEKHH3IFT70AQ86WT1458
PLEKHH3PROB1E7EW31458
PLEKHH3FAM151AQ8WW52454
PLEKHH3ASB15Q8WXK1454
PLEKHH3FRMD7Q6ZUT3453
PLEKHH3NUAK2Q9H093399
PLEKHH3HEATR5BQ9P2D3398
PLEKHH3CNIH1O95406387
PLEKHH3PLEKHA2Q9HB19383
PLEKHH3PLEKHG1Q9ULL1382
PLEKHH3LMOD2Q6P5Q4377
PLEKHH3PLEKHB2Q96CS7372
PLEKHH3ZNF875P10072353

IntAct

71 interactions, top by confidence:

ABTypeScore
RFXANKRFXAPpsi-mi:“MI:0914”(association)0.780
GNAI3RGS12psi-mi:“MI:0914”(association)0.640
NIPAL1ESYT2psi-mi:“MI:0914”(association)0.640
CXCR4TMEM120Bpsi-mi:“MI:0914”(association)0.530
MANSC1KLRG2psi-mi:“MI:0914”(association)0.530
SLC31A1C2orf72psi-mi:“MI:0914”(association)0.530
HAVCR2TCAF2psi-mi:“MI:0914”(association)0.530
EFNB2FAM171A2psi-mi:“MI:0914”(association)0.530
TGFBR2PIK3R2psi-mi:“MI:0914”(association)0.530
PTGER3PIK3R2psi-mi:“MI:0914”(association)0.530
IL4RRHOBTB3psi-mi:“MI:0914”(association)0.530
CLEC11AVWA8psi-mi:“MI:0914”(association)0.530
PTGES3AIPpsi-mi:“MI:0914”(association)0.530
TMEM200ASTX6psi-mi:“MI:0914”(association)0.530
CTDSP2ZMYM6psi-mi:“MI:0914”(association)0.530
GABARAPL2PLEKHH3psi-mi:“MI:0407”(direct interaction)0.440
PLEKHH3Dlg4psi-mi:“MI:0407”(direct interaction)0.440
PB1ESYT2psi-mi:“MI:0914”(association)0.350
MAPK4ILVBLpsi-mi:“MI:0914”(association)0.350
Npc1ESYT2psi-mi:“MI:0914”(association)0.350
PTGES3SBNO1psi-mi:“MI:0914”(association)0.350
AVPR1BKLRG2psi-mi:“MI:0914”(association)0.350
EFNB1KRBA1psi-mi:“MI:0914”(association)0.350
MAGEA8METTL15psi-mi:“MI:0914”(association)0.350
CX3CL1FAM171A2psi-mi:“MI:0914”(association)0.350
SKAP1MYO9Apsi-mi:“MI:0914”(association)0.350
KCNE3PIK3R2psi-mi:“MI:0914”(association)0.350

BioGRID (77): PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS), PLEKHH3 (Affinity Capture-MS)

ESM2 similar proteins: A1L515, A4D2P6, A6QQD2, A8VU90, E1BDF2, O75808, O88995, P0CG25, P22083, Q0IIA6, Q2TA57, Q3B7L1, Q3MIP1, Q3U5Q7, Q3UR50, Q3UR97, Q3UV16, Q400G9, Q5BKX5, Q5EBM0, Q5GH72, Q5SZI1, Q5TM19, Q5U4P2, Q62994, Q659K9, Q6PRD1, Q7Z736, Q861W0, Q86UR1, Q8BNN1, Q8C0R7, Q8CG70, Q8IUW3, Q8IVL6, Q8N398, Q8NAG6, Q8NCW0, Q8R2H1, Q8VCE9

Diamond homologs: A0MP03, A5PF48, B2RTY4, D3ZJP6, E1BPK6, E7EZG2, E9Q634, F4HWY6, F4HXP9, F4I460, F4I507, F4I5Q6, F4IRU3, F4IUG9, F4IVR7, F4JM19, F4K0A6, F4K5J1, F8VQB6, K7U9N8, O00159, O00160, O08638, O74805, O88329, O94477, P05659, P08799, P10587, P19524, P21271, P22467, P24733, P32492, P34092, P34109, P35580, P35748, P35749, P42522

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

155 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance137
Likely benign3
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

2109 predictions. Top by Δscore:

VariantEffectΔscore
17:42669621:CCTG:Cacceptor_loss1.0000
17:42669622:CTGCA:Cacceptor_loss1.0000
17:42669623:T:Cacceptor_loss1.0000
17:42669926:G:Cdonor_gain1.0000
17:42670992:A:ACdonor_gain1.0000
17:42670993:C:CCdonor_gain1.0000
17:42670993:CTT:Cdonor_gain1.0000
17:42670995:T:TAdonor_gain1.0000
17:42671126:GCCAC:Gacceptor_gain1.0000
17:42671127:CCAC:Cacceptor_gain1.0000
17:42671127:CCACC:Cacceptor_gain1.0000
17:42671128:CAC:Cacceptor_gain1.0000
17:42671128:CACC:Cacceptor_gain1.0000
17:42671129:AC:Aacceptor_gain1.0000
17:42671130:CC:Cacceptor_gain1.0000
17:42671131:C:Aacceptor_loss1.0000
17:42671131:C:CCacceptor_gain1.0000
17:42671352:T:TAdonor_gain1.0000
17:42671353:C:Adonor_gain1.0000
17:42671557:TC:Tacceptor_gain1.0000
17:42671558:CC:Cacceptor_gain1.0000
17:42671730:A:ACdonor_gain1.0000
17:42671731:C:CCdonor_gain1.0000
17:42673386:C:CAdonor_gain1.0000
17:42673394:TGTA:Tdonor_loss1.0000
17:42673395:GTAC:Gdonor_loss1.0000
17:42673396:TA:Tdonor_loss1.0000
17:42673397:ACC:Adonor_loss1.0000
17:42673552:CAGAC:Cacceptor_gain1.0000
17:42673557:C:Aacceptor_loss1.0000

AlphaMissense

4981 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:42672232:C:AK310N0.998
17:42672232:C:GK310N0.998
17:42671466:G:TP390H0.997
17:42672290:A:TL291H0.997
17:42672142:G:CS340R0.996
17:42672142:G:TS340R0.996
17:42672144:T:GS340R0.996
17:42673762:A:TL124H0.996
17:42671466:G:CP390R0.995
17:42672239:A:GL308P0.995
17:42672349:G:CF271L0.995
17:42672349:G:TF271L0.995
17:42672351:A:GF271L0.995
17:42673477:C:AW190C0.995
17:42673477:C:GW190C0.995
17:42673479:A:GW190R0.995
17:42673479:A:TW190R0.995
17:42671478:C:AR386I0.994
17:42672290:A:GL291P0.994
17:42673208:A:TL246H0.994
17:42673241:A:GL235P0.994
17:42673415:A:GL211P0.994
17:42673762:A:GL124P0.994
17:42672234:T:CK310E0.993
17:42673241:A:TL235Q0.993
17:42673693:A:TL147H0.993
17:42669436:G:CS733R0.992
17:42669436:G:TS733R0.992
17:42669438:T:GS733R0.992
17:42672158:A:GL335P0.992

dbSNP variants (sampled 300 via entrez): RS1000189149 (17:42668552 G>C,T), RS1000284310 (17:42678731 C>A,T), RS1000558015 (17:42667517 C>A,G), RS1000615881 (17:42675917 T>A,C), RS1000645761 (17:42668813 T>C), RS1000967461 (17:42674066 C>T), RS1001550579 (17:42669774 C>A,T), RS1001626400 (17:42675565 GGCCCCGGCGGCGCAGCCC>G), RS1002115991 (17:42677031 G>C,T), RS1002428507 (17:42675518 C>A,G), RS1003118722 (17:42678110 C>A,G), RS1003160202 (17:42670496 T>G), RS1003352625 (17:42675737 C>A,G,T), RS1003583154 (17:42672005 G>A), RS1003908161 (17:42669411 A>G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST008529_19Tea consumption2.000000e-06
GCST009963_16Cataracts (operation)3.000000e-08

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010091tea consumption measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
FR900359decreases phosphorylation1
benzo(e)pyreneincreases methylation1
ICG 001increases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Irinotecanincreases expression1
Fulvestrantincreases methylation1
Air Pollutantsdecreases expression, increases abundance1
Cisplatindecreases expression1
Estradiolaffects cotreatment, decreases expression1
Formaldehydedecreases expression1
Methapyrileneincreases methylation1
Phthalic Acidsincreases methylation1
Smokedecreases expression1
Tetrachlorodibenzodioxinaffects expression1
Tobacco Smoke Pollutiondecreases expression1
Tunicamycinincreases expression1
Urethaneincreases expression1
Valproic Acidincreases methylation1
Antirheumatic Agentsincreases expression1
Cadmium Chloridedecreases expression1
Thapsigarginincreases expression1
Copper Sulfateincreases expression1
Acrylamideincreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cataract